Skip to main content
. 2021 Jul 9;13:154. doi: 10.1007/s40820-021-00674-8

Fig. 12.

Fig. 12

a Preparation and the catalytic mechanism for CDT enhancement of CoO@AuPt NPs via Fenton reactions and regulating the response environment. b Preparation, the degradation process and the therapy principle of IL@MIL-101(Fe)@BSA-AuNCs NPs for MEDT. GSSH Glutathione disulfide, EPR enhanced permeation and retention, MW microwave, MRI magnetic resonance imaging, MTT microwave thermal therapy, FI fluorescence imaging.

Adapted from a Ref. [426], b Ref. [131] with permission